{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:45:56Z","timestamp":1777117556460,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bpobgyn.2025.102650","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:52:24Z","timestamp":1753253544000},"page":"102650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Understanding, detecting, and managing the \u201clate\u201d anemia of hemolytic disease of the fetus and newborn"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-582X","authenticated-orcid":false,"given":"Robert D.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin K.","family":"Ohls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102650_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00431-022-04724-0","article-title":"History and current standard of postnatal management in hemolytic disease of the fetus and newborn","volume":"182","author":"De Winter","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102650_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41372-024-01872-z","article-title":"Erythrokinetic mechanism(s) causing the \"late anemia\" of hemolytic disease of the fetus and newborn","volume":"44","author":"Christensen","year":"2024","journal-title":"J Perinatol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102650_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41372-023-01730-4","article-title":"A \"gold standard\" test for diagnosing and quantifying hemolysis in neonates and infants","volume":"43","author":"Christensen","year":"2023","journal-title":"J Perinatol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102650_bib4","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41372-023-01785-3","article-title":"Alloimmune hemolytic disease of the fetus and newborn: genetics, structure, and function of the commonly involved erythrocyte antigens","volume":"43","author":"Christensen","year":"2023","journal-title":"J Perinatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102650_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijns9020024","article-title":"Foetal hemoglobin as a marker of bone marrow suppression secondary to anti-Kell alloimmunisation","volume":"9","author":"Morales Painamil","year":"2023","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib6","article-title":"Duration of hemolysis among infants with hemolytic disease of the fetus and newborn","volume":"14","author":"Bahr","year":"2024","journal-title":"J Perinatol"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib7","series-title":"Wintrobe's clinical hematology","article-title":"Anemia: general considerations","author":"Means","year":"2024"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102650_bib8","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1542\/neo.24-6-e343","article-title":"Diagnosing anemia in neonates: an evidence-based approach","volume":"24","author":"Christensen","year":"2023","journal-title":"NeoReviews"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102650_bib9","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1542\/peds.2008-2654","article-title":"Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system","volume":"123","author":"Jopling","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102650_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.clp.2015.04.005","article-title":"Reference intervals in neonatal hematology","volume":"42","author":"Henry","year":"2015","journal-title":"Clin Perinatol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/jp.2015.140","article-title":"Reference intervals for reticulocyte parameters of infants during their first 90 days after birth","volume":"36","author":"Christensen","year":"2016","journal-title":"J Perinatol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102650_bib12","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1002\/ajh.25904","article-title":"Pediatric hematology normal ranges derived from pediatric primary care patients","volume":"95","author":"Staffa","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/jp.2015.140","article-title":"Reference intervals for reticulocyte parameters of infants during their first 90 days after birth","volume":"36","author":"Christensen","year":"2016","journal-title":"J Perinatol"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib14","series-title":"Neonatal hematology","first-page":"156","article-title":"Neonatal hemolysis","author":"Glader","year":"2012"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib15","series-title":"Blood transfusion in clinical medicine","author":"Mollison","year":"1961"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib16","first-page":"6","article-title":"Pure red cell anemia due to autoantibodies","volume":"26","author":"Gasser","year":"1955","journal-title":"Sang"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.17.1.37","article-title":"Damage to the bone marrow due to Rh antibody","volume":"17","author":"Giblett","year":"1956","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2141.1965.tb06585.x","article-title":"London, the \u201clate anemia of hemolytic disease of the newborn","volume":"11","author":"Hurdel","year":"1965","journal-title":"Brit J Haemaotl"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.16.1.15","article-title":"Observations on the convalescent phase of erythroblastosis fetalis","volume":"16","author":"Hyman","year":"1955","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102650_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1542\/peds.23.2.314","article-title":"Serial study of bone marrow in hemolytic disease of the newborn (erythroblastosis fetalis)","volume":"23","author":"Dillon","year":"1959","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102650_bib21","first-page":"439","article-title":"Delayed anemia in erythroblastosis fetalis","volume":"55","author":"Strand","year":"1972","journal-title":"Minn Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102650_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00441365","article-title":"Late anaemia in infants with rhesus haemolytic disease treated with intensive phototherapy","volume":"130","author":"Ebbesen","year":"1979","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5694\/j.1326-5377.1956.tb56640.x","article-title":"A study of the anemia following exchange transfusion in haemolytic disease of the newborn","volume":"2","author":"Robertson","year":"1956","journal-title":"Med J Aust"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib24","series-title":"Hematology of infancy and childhood","first-page":"65","article-title":"Isoimmune hemolytic diseases","author":"Zipursky","year":"1987"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102650_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(89)80092-7","article-title":"Late hyporegenerative anemia in Rh hemolytic disease","volume":"115","author":"Koenig","year":"1989","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102650_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1542\/peds.90.5.678","article-title":"Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease","volume":"90","author":"Ohls","year":"1992","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102650_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102948","article-title":"The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates","volume":"59","author":"Tyndall","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib28","doi-asserted-by":"crossref","first-page":"54.e1","DOI":"10.1016\/j.ajog.2007.05.030","article-title":"Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion","volume":"198","author":"De Boer","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1157004","article-title":"Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China","volume":"11","author":"Pan","year":"2023","journal-title":"Front Pediatr"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102650_bib30","doi-asserted-by":"crossref","first-page":"e976","DOI":"10.1016\/S2352-3026(23)00285-5","article-title":"Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in The Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial","volume":"10","author":"Ree","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2022.07.003","article-title":"An end-tidal carbon monoxide nomogram for term and late-preterm infants","volume":"250","author":"Bao","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib32","article-title":"Neonatal\/perinatal diagnosis of hemolysis using ETCOc","volume":"22","author":"Christensen","year":"2024","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41372-021-01207-2","article-title":"Reference intervals for end-tidal carbon monoxide of preterm neonates","volume":"42","author":"Pakdeeto","year":"2022","journal-title":"J Perinatol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2025.102650_bib34","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/trf.14171","article-title":"Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk","volume":"57","author":"Li","year":"2017","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102650_bib35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/trf.14446","article-title":"More data needed to establish maternal breast milk IgG as cause for anti-D hemolytic disease of fetus and newborn","volume":"58","author":"Strauss","year":"2018","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102650_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/trf.15154","article-title":"Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn","volume":"59","author":"Leonard","year":"2019","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102650_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/tme.12672","article-title":"Do red cell alloantibodies continue to challenge breast fed babies?","volume":"30","author":"Rasalam","year":"2020","journal-title":"Transfus Med"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102650_bib38","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1111\/trf.17548","article-title":"Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia","volume":"63","author":"Abels","year":"2023","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102650_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.103974","article-title":"Breast milk induced immune haemolytic disease of newborn due to anti-c: a case report","volume":"63","author":"Sahni","year":"2024","journal-title":"Transfus Apher Sci"},{"issue":"3\u20134","key":"10.1016\/j.bpobgyn.2025.102650_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000163796","article-title":"Erythropoietin does not cross the placenta into the fetus","volume":"61","author":"Zanjani","year":"1993","journal-title":"Pathobiology"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib41","article-title":"Term umbilical cord blood, fully tested and processed, as the source of red blood cell transfusions for extremely-low-gestational age neonates","volume":"19","author":"Bahr","year":"2024","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102650_bib42","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41372-023-01833-y","article-title":"Banked term umbilical cord blood to meet the packed red blood cell transfusion needs of extremely-low-gestational-age neonates: a feasibility analysis","volume":"44","author":"Christensen","year":"2024","journal-title":"J Perinatol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102650_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1537-2995.2010.02926.x","article-title":"Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities","volume":"51","author":"Mock","year":"2011","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib44","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","article-title":"A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102650_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","author":"Juul","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants","volume":"95","author":"Shannon","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib47","unstructured":"Ohls RK, Cannon DC, McConaghy S, Christensen RD, J. Lowe L. Serum erythropoietin concentrations correlate with neurocognitive outcomes in a randomized trial of erythropoiesis-stimulating agent administration to preterm infants E-PAS 2015:3856.126."},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102650_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(95)70086-2","article-title":"Effect of recombinant human erythropoietin on the switchover from fetal to adult hemoglobin synthesis in preterm infants","volume":"127","author":"Bard","year":"1995","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102650_bib49","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1203\/00006450-199605000-00015","article-title":"Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study)","volume":"39","author":"Ovali","year":"1996","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102650_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1515\/JPM.1999.014","article-title":"Late hyporegenerative anemia in neonates with rhesus hemolytic disease","volume":"27","author":"al-Alaiyan","year":"1999","journal-title":"J Perinat Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102650_bib51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000020937","article-title":"Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease","volume":"14","author":"Zuppa","year":"1999","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000048000","article-title":"Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion","volume":"17","author":"Nicaise","year":"2002","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102650_bib53","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/MPH.0b013e3181cf444c","article-title":"Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization","volume":"32","author":"Zuppa","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clp.2004.03.006","article-title":"Long-acting erythropoietin: clinical studies and potential uses in neonates","volume":"31","author":"Ohls","year":"2004","journal-title":"Clin Perinatol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102650_bib55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clp.2015.04.016","article-title":"Darbepoetin administration in term and preterm neonates","volume":"42","author":"Patel","year":"2015","journal-title":"Clin Perinatol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102650_bib56","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","article-title":"A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib57","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3859","article-title":"Preschool assessment of preterm infants treated with darbepoetin and erythropoietin","volume":"137","author":"Ohls","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib58","article-title":"A practical guide to reducing\/eliminating red blood cell transfusions in the neonatal intensive care unit","volume":"22","author":"Ohls","year":"2024","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102650_bib59","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-065091","article-title":"Antimicrobial stewardship programs in neonates: a meta-analysis","volume":"153","author":"Mascarenhas","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib60","article-title":"Antibiotic use among extremely low birth-weight infants from 2009 to 2021: a retrospective observational study","author":"Flannery","year":"2024","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.bpobgyn.2025.102650_bib61","article-title":"Identifying barriers to complying with new restrictive NICU transfusion guidelines","volume":"16","author":"Tweddell","year":"2025","journal-title":"J Perinatol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:25:27Z","timestamp":1777116327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693425000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":61,"alternative-id":["S1521693425000744"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102650","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding, detecting, and managing the \u201clate\u201d anemia of hemolytic disease of the fetus and newborn","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102650"}}